Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov
Created by Dmytri Ivanov

Funding radical lifespan extension

We back longevity biotech companies developing technologies which can significantly extend healthy human lifespan and are scalable for everyone

Why invest in longevity?

Why invest in longevity?

Biotech Breakthroughs

Breakthroughs in multiple areas including AI, synthetic biology, stem cell therapies, gene sequencing and editing, protein engineering, tissue engineering, and more mean that we now have the tools needed to begin tackling aging in a meaningful way.

Biotech Breakthroughs

Breakthroughs in multiple areas including AI, synthetic biology, stem cell therapies, gene sequencing and editing, protein engineering, tissue engineering, and more mean that we now have the tools needed to begin tackling aging in a meaningful way.

Biotech Breakthroughs

Breakthroughs in multiple areas including AI, synthetic biology, stem cell therapies, gene sequencing and editing, protein engineering, tissue engineering, and more mean that we now have the tools needed to begin tackling aging in a meaningful way.

An Aging Society

Demographics around the globe are getting older putting pressure on economies and healthcare systems. The demand for longevity interventions will continue to grow as aging becomes a root cause of a majority of deaths across the western world.

An Aging Society

Demographics around the globe are getting older putting pressure on economies and healthcare systems. The demand for longevity interventions will continue to grow as aging becomes a root cause of a majority of deaths across the western world.

An Aging Society

Demographics around the globe are getting older putting pressure on economies and healthcare systems. The demand for longevity interventions will continue to grow as aging becomes a root cause of a majority of deaths across the western world.

A Trillion-Dollar Opportunity

The first therapies to extend healthy life by 10+ years will open up a vast untapped market. We focus on scalable solutions for global populations, not just the wealthy. With biotech tech maturing and valuations low, there’s a rare opportunity to access the next wave of industry unicorns.

A Trillion-Dollar Opportunity

The first therapies to extend healthy life by 10+ years will open up a vast untapped market. We focus on scalable solutions for global populations, not just the wealthy. With biotech tech maturing and valuations low, there’s a rare opportunity to access the next wave of industry unicorns.

A Trillion-Dollar Opportunity

The first therapies to extend healthy life by 10+ years will open up a vast untapped market. We focus on scalable solutions for global populations, not just the wealthy. With biotech tech maturing and valuations low, there’s a rare opportunity to access the next wave of industry unicorns.

A Healthcare Revolution

Longevity biotech is the leading edge of a shift to personalised and preventative healthcare. Over the coming decades medicine will mean extending our healthspan instead of just keeping us alive in poor health.

A Healthcare Revolution

Longevity biotech is the leading edge of a shift to personalised and preventative healthcare. Over the coming decades medicine will mean extending our healthspan instead of just keeping us alive in poor health.

A Healthcare Revolution

Longevity biotech is the leading edge of a shift to personalised and preventative healthcare. Over the coming decades medicine will mean extending our healthspan instead of just keeping us alive in poor health.

Our Mission

Our Mission

Our Mission

What is radical lifespan extension?

What is radical lifespan extension?

At LongGame, we invest exclusively in technologies designed to extend human life beyond current limits—not just optimizing health but pushing towards indefinite longevity.

We back bold innovations that target aging at its root cause, aiming to slow or reverse its effects.

We back bold innovations that target aging at its root cause, aiming to slow or reverse its effects.

Hard rule: Every company we invest in must have the potential to extend healthy human lifespan by at least 10+ years.

Hard rule: Every company we invest in must have the potential to extend healthy human lifespan by at least 10+ years.

Our portfolio includes novel and cutting edge approaches to life extension that can push maximum lifespan beyond its current limits.

Our portfolio includes novel and cutting edge approaches to life extension that can push maximum lifespan beyond its current limits.

Created by Dmytri Ivanov
Created by Dmytri Ivanov

Our Principles

Our Principles

Our Principles

What companies do we back?

What companies do we back?

Radical Lifespan Extension

We invest in companies dedicated to achieving significant advancements in life extension, targeting at least a 10% increase in healthy lifespan.

Scaling Society Wide

Longevity for everyone not just the few. Our investments are directed towards technologies and treatments with the potential for broad scalability, benefitting society as a whole. 

Integrity & Evidence

We seek out companies with a strong ethical foundation and robust scientific backing. Our investments are grounded in credible research.

Contact

Contact

Contact

Get in touch!

Get in touch!

We'd love to hear from you if you, whether you are looking for investment, or interested in learning more about the fund and our portfolio.

LongGame Advisors Ltd is an Appointed Representative of Robert Quinn Advisory LLP, which is authorised and regulated by the Financial Conduct Authority. LongGame Advisors Ltd is incorporated in England and the registered office is at 28 Redfield Lane, London, United Kingdom, SW5 0RQ.

The investment products and services of LongGame Advisors Ltd are only available to professional clients and eligible counterparties. They are not available to retail clients. This website does not constitute an offer to buy or sell shares in any of the products offered by LongGame Advisors Ltd.

LongGame Advisors Ltd is an Appointed Representative of Robert Quinn Advisory LLP, which is authorised and regulated by the Financial Conduct Authority. LongGame Advisors Ltd is incorporated in England and the registered office is at 28 Redfield Lane, London, United Kingdom, SW5 0RQ.

The investment products and services of LongGame Advisors Ltd are only available to professional clients and eligible counterparties. They are not available to retail clients. This website does not constitute an offer to buy or sell shares in any of the products offered by LongGame Advisors Ltd.

LongGame Advisors Ltd is an Appointed Representative of Robert Quinn Advisory LLP, which is authorised and regulated by the Financial Conduct Authority. LongGame Advisors Ltd is incorporated in England and the registered office is at 28 Redfield Lane, London, United Kingdom, SW5 0RQ.

The investment products and services of LongGame Advisors Ltd are only available to professional clients and eligible counterparties. They are not available to retail clients. This website does not constitute an offer to buy or sell shares in any of the products offered by LongGame Advisors Ltd.